These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 4208339

  • 1. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S, Johnson R.
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time-dependent prognostic factors in advanced prostatic cancer.
    Suciu S, Sylvester RJ, Yamanaka H.
    Prog Clin Biol Res; 1990 Apr; 357():203-15. PubMed ID: 2217465
    [No Abstract] [Full Text] [Related]

  • 5. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
    von Lieven H, Hahn D.
    MMW Munch Med Wochenschr; 1977 Aug 26; 119(34):1089-92. PubMed ID: 408657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metastatic prostate carcinoma to the mandible: report of case.
    Mesa ML.
    J Oral Surg; 1977 Feb 26; 35(2):133-5. PubMed ID: 264506
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M, Lutherer S, Terhorst B.
    Urologe A; 1981 Jul 26; 20(4):223-7. PubMed ID: 7196632
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis and treatment of prostatic carcinoma].
    Klug W.
    Zentralbl Chir; 1968 Mar 09; 93(10):362-6. PubMed ID: 5674208
    [No Abstract] [Full Text] [Related]

  • 14. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A, Morvay J, Vécsei B.
    Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract] [Full Text] [Related]

  • 15. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy].
    Thijs LG, Poelman JR, Noll WL.
    Ned Tijdschr Geneeskd; 1969 Jul 26; 113(30):1303-9. PubMed ID: 5802998
    [No Abstract] [Full Text] [Related]

  • 16. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul 26; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 17. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
    Moore MR, Troner MB, DeSimone P, Birch R, Irwin L.
    Cancer Treat Rep; 1986 Apr 26; 70(4):541-2. PubMed ID: 3698053
    [No Abstract] [Full Text] [Related]

  • 18. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH, Bauer HW, Dati F.
    Ric Clin Lab; 1984 Apr 26; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic factors of advanced prostatic carcinoma.
    Lukkarinen O, Lehikoinen K.
    Ann Chir Gynaecol Suppl; 1993 Apr 26; 206():9-13. PubMed ID: 8291878
    [Abstract] [Full Text] [Related]

  • 20. [Prostatic cancer and acid phosphatase].
    Mischol HR.
    Schweiz Med Wochenschr; 1969 Sep 20; 99(38):1357-61. PubMed ID: 5349533
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.